Ultragenyx Pharmaceutical | RARE - Umsatzerlöse





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
BioMarin Pharmaceutical USD 766M 109M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Ionis Pharmaceuticals USD 246M 43M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Kyowa Hakko Kirin JPY 118.47B 28.91B 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Moderna USD 389M 289M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
PTC Therapeutics USD 273M 108.3M 2026-03
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Ultragenyx Pharmaceutical USD 136M 71M 2026-03
Vertex Pharmaceuticals USD 2.99B 200M 2026-03
Xoma USD 25K 5M 2024-09